|Articles|March 1, 2012
- Pharmaceutical Executive-03-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2012
Leading in Emerging Markets
Advertisement
Articles in this issue
over 13 years ago
Novartis: LEADing in Emerging Marketsalmost 14 years ago
How Can We Fix the FDA?almost 14 years ago
The Italian's Jobalmost 14 years ago
Off the Hook? Pharm Exec's Annual Press Auditalmost 14 years ago
The Maestrosalmost 14 years ago
The (Life) Science of Digital Connectionsalmost 14 years ago
Judging a Pill by its Coveralmost 14 years ago
When Talk is Not So CheapNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
